MARIANA VIEGAS

Dr. MARIANA VIEGAS

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2020 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
PDF file
SGStephanie Goya
Stephanie Goya
MGMónica Galiano
Mónica Galiano
INInne Nauwelaers
Inne Nauwelaers
ATAlfonsina Trento
Alfonsina Trento
POPeter J. Openshaw
Peter J. Openshaw
MVMARIANA VIEGAS
MARIANA VIEGAS
Background: Human respiratory syncytial virus (RSV) is classified into antigenic subgroups A and B. Thirteen genotypes have been defined for RSV‐A and 20 for RSV‐B, without any consensus on genotype definition.Methods: We evaluated clustering of RSV sequences published in GenBank until February 2018 to define genotypes by using maximum likelihood and Bayesian phylogenetic analyses and average p‐distances.Results: We compared the patterns of sequence clustering of complete genomes; the three surface glycoproteins genes (SH, G, and F, single and concatenated); the ectodomain and the 2nd hypervariable region of G gene. Although complete genome analysis achieved the best resolution, the F, G, and G‐ectodomain phylogenies showed similar topologies with statistical support comparable to complete genome. Based on the widespread geographic representation and large number of available G‐ectodomain sequences, this region was chosen as the minimum region suitable for RSV genotyping. A genotype was defined as a monophyletic cluster of sequences with high statistical support (≥80% bootstrap and ≥0.8 posterior probability), with an intragenotype p‐distance ≤0.03 for both subgroups and an intergenotype p‐distance ≥0.09 for RSV‐A and ≥0.05 for RSV‐B. In this work, the number of genotypes was reduced from 13 to three for RSV‐A (GA1‐GA3) and from 20 to seven for RSV‐B (GB1‐GB7). Within these, two additional levels of classification were defined: subgenotypes and lineages. Signature amino acid substitutions to complement this classification were also identified.Conclusions: We propose an objective protocol for RSV genotyping suitable for adoption as an international standard to support the global expansion of RSV molecular surveillance.

9 March 2022 in Journal of Clinical Virology
Verified
Journal Article
Closed access
ADAcuña Dolores
Acuña Dolores
GSGoya Stephanie
Goya Stephanie
MJMercedes Soledad Nabaes Jodar
Mercedes Soledad Nabaes Jodar
GÉGrandis Érica
Grandis Érica
AMAlicia S Mistchenko
Alicia S Mistchenko
MVMARIANA VIEGAS
MARIANA VIEGAS

25 June 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SGStephanie Goya
Stephanie Goya
LVLaura E Valinotto
Laura E Valinotto
ETEstefania Tittarelli
Estefania Tittarelli
GRGabriel L Rojo
Gabriel L Rojo
MJMercedes S Nabaes Jodar
Mercedes S Nabaes Jodar
MVMARIANA VIEGAS
MARIANA VIEGAS
Over the last decade, the number of viral genome sequences deposited in available databases has grown exponentially. However, sequencing methodology vary widely and many published works have relied on viral enrichment by viral culture or nucleic acid amplification with specific primers rather than through unbiased techniques such as metagenomics. The genome of RNA viruses is highly variable and these enrichment methodologies may be difficult to achieve or may bias the results. In order to obtain genomic sequences of human respiratory syncytial virus (HRSV) from positive nasopharyngeal aspirates diverse methodologies were evaluated and compared. A total of 29 nearly complete and complete viral genomes were obtained. The best performance was achieved with a DNase I treatment to the RNA directly extracted from the nasopharyngeal aspirate (NPA), sequence-independent single-primer amplification (SISPA) and library preparation performed with Nextera XT DNA Library Prep Kit with manual normalization. An average of 633,789 and 1,674,845 filtered reads per library were obtained with MiSeq and NextSeq 500 platforms, respectively. The higher output of NextSeq 500 was accompanied by the increasing of duplicated reads percentage generated during SISPA (from an average of 1.5% duplicated viral reads in MiSeq to an average of 74% in NextSeq 500). HRSV genome recovery was not affected by the presence or absence of duplicated reads but the computational demand during the analysis was increased. Considering that only samples with viral load ≥ E+06 copies/ml NPA were tested, no correlation between sample viral loads and number of total filtered reads was observed, nor with the mapped viral reads. The HRSV genomes showed a mean coverage of 98.46% with the best methodology. In addition, genomes of human metapneumovirus (HMPV), human rhinovirus (HRV) and human parainfluenza virus types 1–3 (HPIV1-3) were also obtained with the selected optimal methodology.

1 September 2021 in Veterinary Microbiology
Verified
Journal Article
Closed access
NFNadia Analía Fuentealba
Nadia Analía Fuentealba
GMGastón Moré
Gastón Moré
MBMaría Emilia Bravi
María Emilia Bravi
JUJuan Manuel Unzaga
Juan Manuel Unzaga
LFLorena De Felice
Lorena De Felice
Carlos Javier PaneiCarlos Javier Panei
Carlos Javier Panei

10 December 2021 in Frontiers in Medicine
Verified
Journal Article
Open access
CTCarolina Torres
Carolina Torres
LMLaura Mojsiejczuk
Laura Mojsiejczuk
DADolores Acuña
Dolores Acuña
SASofía Alexay
Sofía Alexay
AAAriel Amadio
Ariel Amadio
MVMARIANA VIEGAS
MARIANA VIEGAS
SARS-CoV-2 variants with concerning characteristics have emerged since the end of 2020. Surveillance of SARS-CoV-2 variants was performed on a total of 4,851 samples from the capital city and 10 provinces of Argentina, during 51 epidemiological weeks (EWs) that covered the end of the first wave and the ongoing second wave of the COVID-19 pandemic in the country (EW 44/2020 to EW 41/2021). The surveillance strategy was mainly based on Sanger sequencing of a Spike coding region that allows the identification of signature mutations associated with variants. In addition, whole-genome sequences were obtained from 637 samples. The main variants found were Gamma and Lambda, and to a lesser extent, Alpha, Zeta, and Epsilon, and more recently, Delta. Whereas, Gamma dominated in different regions of the country, both Gamma and Lambda prevailed in the most populated area, the metropolitan region of Buenos Aires. The lineages that circulated on the first wave were replaced by emergent variants in a term of a few weeks. At the end of the ongoing second wave, Delta began to be detected, replacing Gamma and Lambda. This scenario is consistent with the Latin American variant landscape, so far characterized by a concurrent increase in Delta circulation and a stabilization in the number of cases. The cost-effective surveillance protocol presented here allowed for a rapid response in a resource-limited setting, added information on the expansion of Lambda in South America, and contributed to the implementation of public health measures to control the disease spread in Argentina.